Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue SUPPL. 45, 1998, Pages 15-21

  Menz, G ^a   Ying, S ^b   Durham, S R ^b   Corrigan, C J ^b   Robinson, D S ^b   Hamid, Q ^c   Pfister, R ^a   Hmbert, M ^b,d   Kay, A B ^b  

^a Hochgebirgsklinik Davos Wolfgang ^*  (Switzerland)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Asthma; Atopy; Cytokines

Indexed keywords

ALLERGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 5;

ASTHMA; ATOPY; CELL ADHESION; CONFERENCE PAPER; DISEASE SEVERITY; IMMUNOPATHOLOGY; INFLAMMATION; PRIORITY JOURNAL;

ANIMALS; ASTHMA; BRONCHI; CHEMOKINES; CYTOKINES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKINS; MACROPHAGES;

EID: 0031720045     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04934.x     Document Type: Conference Paper

References (57)

1. Herxheimer H. The late bronchial reaction in induced asthma. Int Arch Allergy Appl Immunol 1952;3:323-8.
2. Solley GO, Gleich GJ, Jordan RE, Schroeter AL. Late phase of the immediate wheal and flare skin reactions: its dependence on IgE antibodies J Clin Invest 1976;58: 408-20.
3. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocyte activated eosinophils and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol1988;141:4159-64.
4. Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gene cluster, IL-3, IL-4, IL- 5 and GMCSF in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
5. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2- like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
6. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and GM-CSF in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Imrnunol 1992;148:2390-4.
7. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-13
8. Bradley BL, Azzawi M, Jacobson M, et al. Eosinophils, Tlymphocytes, mast cells, neutrophils and macrophages in bronchial biopsies from atopic asthmatics: comparison with atopic nonasthma and normal controls and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991 81661 -74.
9. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
10. Ying S, Durham SR, Barkans J, et al. T cells are the principal source of interleukin-5 mRNA in allergeninduced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
11. Collins PD, Marleau S, Griffith-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:1169-74.
12. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:258-65.
13. Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant-cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-2.
14. Ponath PD, Qiu S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding and functional properties provide a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12
15. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992;148:3543-9.
16. Wardlaw AJ, Moqbel R, Kay AB. Eosinophils: biology and role in disease. Adv Immunol 1995;60:151-266.
17. Rackeman FM. A working classification of asthma. Am J Med 1947;3:601-6.
18. Bentley AM, Menz G, Storz C, et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma: relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992;146:500-6.
19. Humbert M, Grant JA, Taborda-Barata L, et al. High affinity IgE receptor (Fc,RI)-bearing cells in bronchial biopsies from atopic and non-Atopic asthma. Am J Respir Crit Care Med 1996;153:1931-7.
20. Godard P, Bousquet J, Michel FB. Extrinsic and intrinsic asthma: still a matter for debate? Clin Asthma Rev 1997;1:19-22.
21. Wiithrich B, Schindler C, Leuenberg P, Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. Int Arch Allergy Immunol 1995;106:149-56.
22. Cartier A, Thompson NC, Frith PA, Roberts R, Hargreave FE. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway calibre. J Allergy Clin Immunol 1982;70:170-7
23. Dorward AJ, Collof MJ, MacKay NS, McSharry C, Thompson NC. Effect of house dust mite avoidance measures on adult atopic asthma. Thorax 1988;43:95-105.
24. Bousquet J, Chanez P, Lacoste J-Y, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
25. Djukanovic R, Wilson JW, Britten KM. Mucosal inflammation in asthma. Am Rev Respir Dis 1990142:434-57.
26. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-7.
27. Ying S, Durham SR, Corrigan C, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2 type (IL-4 and IL-5) and TH1 type (IL-2 and IFNy) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-87.
28. Humbert M. Pro-eosinophilic cytokines in asthma. Clin Exp Allergy 1996;26:123-7.
29. Walker C, Virchow C Jr, Bruijnzeel PLB, Blaser K. T cell subsets and their soluble product regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991;146: 1829-35
30. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr. Allergic and non-Allergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and broncho-Alveolar lavage. Am Rev Respir Dis 1992;146:109-15.
31. Kroegel C, Jager L, Walker C. Is there a place for intrinsic asthma as a distinct immunopathological entity? Eur Respir J 1997;10:513-15.
32. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
33. Del Prete GF, Maggi E, Parronchi I? IL-4 is an essential co-factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193-8.
34. Humbert M, Durham SR, Ying S, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from atopic and non-Atopic asthmatics: evidence against "intrinsic" asthma being a distinct immunopathological entity. Am J Respir Crit Care Med 1996;154:1497-1504.
35. Humbert M, Ying S, Corrigan C, et al. Bronchial mucosal gene expression of the genes encoding CC-chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-Active cytokines IL-5, GM-CSF and IL-3. Am J Respir Cell Mol Biol 1997;16:1-8.
36. Ying S, Humbert M, Barkans J, et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8' T cells, eosinophils and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997;158:3539-44.
37. Yasruel Z, Humbert M, Kotsimbos ATC, et al. Expression of membrane-bound and soluble interleukin-5 alpha receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics. Am J Respir Crit Care Med 1997; 155:1413-18
38. Humbert M, Durham SR, Kimmitt P, et al. Elevated expression of mRNA encoding interleukin-13 in the bronchial mucosa of atopic and non-Atopic asthmatics. J Allergy Clin Immunol 1927;99:657-65.
39. Kotsimbos ATC, Humbert M, Minshall E, et al. Upregulation of aGM-CSF-receptor in non-Atopic but not in atopic asthma. J Allergy Clin Immunol 1997;99:666-72.
40. Humbert M, Corrigan CJ, Durham SR, Kimmitt P, Till SJ, Kay AB. Relationship between bronchial mucosal interleukin-4 and interleukin-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997;156:704-8.
41. Humbert M, Robinson DS, Assoufi B, Kay AB, Durham SR. Safety of fibreoptic bronchoscopy in asthmatics and control subjects and effect on asthma control over two weeks. Thorax 1996;51:664-9.
42. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14
43. Drazen JM, Arm JP, Austen KE Sorting out the cytokines of asthma. J Exp Med 1996;183:1-5.
44. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today 1994;15:127-33.
45. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994;6:865-73.
46. Powell N, Humbert M, Durham SR, Assoufi B, Kay AB, Corrigan C. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J 1996;9:2454-60.
47. Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A. Recombinant interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 1989;19: 701-5
48. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. IL-5 enhances the in v i m adhesion of human eosinophils, but not neutrophils in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:258-65
49. Bradding P, Roberts JA, Britten KM, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-A in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1995;10:471-80.
50. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin-5 and granulocyte macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-24.
51. Dubucquoi S, Desreumaux P, Janin A, et al. Interleukin-5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 1994; 1791703-8
52. Minty A, Chalon P, Derocq JM, et al. Interleukin 13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-50.
53. Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599-1604.
54. Durham SR, Gould HJ, Thienes CP, et al. Expression of E germ-line gene transcripts and mRNA for the E heavy chain of IgE in nasal B cells and the effects of topical steroids. Eur J Immunol 1997;27:2899-2906.
55. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virusspecific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981;305:841-6.
56. Poulter LW, Janossy G, Power C, Sreenan S, Burke C. Immunological/ physiological relationships in asthma: potential regulation by lung macrophages. Immunol Today 1994;15:258-61
57. Mehlhop PD, van de Rijn M, Goldberg AB, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA. 1997;94:1344-9.